深度规范性轨道测量用于识别关节白质在阿尔茨海默病中的宏观和微观结构异常
概括
深度规范 Tractometry (DNT) 使用一个变化的自编码器来绘制大脑白质结构和检测异常. 这一框架显示了确定神经退行性疾病变化的高准确性的前景.
科学领域:
- 神经成像是一种神经成像.
- 计算神经科学是一种神经科学.
- 生物医学工程 生物医学工程
背景情况:
- 大脑白质的完整性对认知功能至关重要.
- 像阿尔茨海默氏症这样的神经退行性疾病会导致白质微观结构的改变.
- 目前分析白质异常的方法在细度测绘方面存在局限性.
研究的目的:
- 引入深度规范性轨道测量 (DNT) 框架,用于分析大脑白质.
- 为了编码白质片段的联合宏观结构和微观结构配置文件.
- 在神经退行性疾病中检测和绘制沿途异常.
主要方法:
- 开发了一个基于变量自编码器 (VAE) 的框架 (DNT).
- 在健康对照数据上训练DNT,以学习规范性通道分布.
- 在一个独立的队列中使用转移学习评估了DNT的概括性.
- 将DNT结果与捆绑分析 (BUAN) 曲率测量管道进行比较.
主要成果:
- DNT成功地划分了沿途的微观和宏观结构异常.
- 在轻度认知障碍和阿尔茨海默病队伍中检测到广泛的扩散性异常.
- DNT的调查结果与已建立的BUAN管道结果密切一致.
- 证明了区分异构异常与通道宏观结构的潜力.
结论:
- DNT为分析白质管道完整性提供了一个强大的框架.
- 该框架显示了改善对白质变化的微量测绘的前景.
- DNT具有显著的潜力,可以改善与神经退行性疾病相关的变化的检测.
更多相关视频
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
39.7K
13:26Measuring Connectivity in the Primary Visual Pathway in Human Albinism Using Diffusion Tensor Imaging and Tractography
Published on: August 11, 2016
12.2K
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
